Netherlands: Price ceiling prevents cost rises in three approved hospital merger deals
Three hospitals in three regions of the Netherlands have been approved by the Netherlands Competition Authority to go ahead with their perspective mergers while simultaneously agreeing to self-impose a price ceiling. The maximum prices allowed at the merged hospitals are also to be annually indexed. According to the NMa, it is the job of the health insurer to determine the price-quality ratio for the hospitals. The NMa said in a statement that the body is confident the pricing can be adequately determined by the insurers, as they have “already demonstrated” the ability to do so.
Featured News
Judge Allows Depositions of LinkedIn Leaders in Antitrust Case
Aug 5, 2026 by
CPI
AstraZeneca, Bristol Myers Dismiss Merger Talk Speculation
Aug 5, 2026 by
CPI
Senator Presses Trump Antitrust Nominee Over FCC’s Role in Content Oversight
Aug 5, 2026 by
CPI
Australia’s Competition Watchdog Opens Mobile Network Inquiry
Aug 5, 2026 by
CPI
EU Accuses Temu of Obstructing Foreign Subsidies Inspection in Dublin
Aug 5, 2026 by
CPI
Antitrust Mix by CPI
Antitrust Chronicle® – Antitrust Compliance
Jul 20, 2026 by
CPI
Your Antitrust Compliance Program: A Strong Voice in Your Defense
Jul 20, 2026 by
Joe Murphy
Antitrust Compliance for the AI Pricing Era
Jul 20, 2026 by
Alejandra Uria & Andre Geverola
Race to Report: Antitrust Leniency in the Whistleblower Era
Jul 20, 2026 by
Brian R. Faerstein & Nicole H. Sprinzen
Antitrust-By-Design: Competition Compliance in Digital Markets
Jul 20, 2026 by
Marcos Drummond Malvar, Gabriela Costa Carvalho Forsman & Luciana Mendes